主体和肠道微生物群之间的对话揭示了化疗的"银子弹"治疗选择
1State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen, Fujian 361102, China.
Cell host & microbe
|September 12, 2024
概括
化疗通过诱导上皮细胞亡,导致肠道损伤和微生物群失衡. 这种细胞损伤阻碍了肠道.
科学领域:
- 微生物学 微生物学
- 胃肠病学 胃肠病学
- 细胞生物学 细胞生物学
背景情况:
- 化疗通常会诱导肠道微生物群失生症和胃肠道损伤.
- 了解将化疗与肠道功能障碍联系在一起的机制对于患者护理至关重要.
研究的目的:
- 研究化疗诱导的上皮细胞亡如何影响肠道微生物群和恢复.
- 阐明化学疗法相关的肠道损伤和失能症背后的分子机制.
主要方法:
- 利用小鼠模型研究化疗对肠道的影响.
- 分析了上皮细胞亡,微生物群组成和基因表达变化.
- 评估了这些变化对肠道愈合的影响.
主要成果:
- 化学疗法诱导的上皮细胞亡被确定为微生物群失衡的关键驱动因素.
- 在化疗后,肠表皮发生了显著的转录性重新连接.
- 发现这些分子和微生物的变化延迟了肠道的恢复.
结论:
- 表皮细胞亡是启动化疗诱导的肠道失生症的关键因素.
- 向化疗诱导的上皮细胞亡可能是改善肠道健康和加速恢复的策略.
- 需要进一步研究宿主细胞死亡和微生物群落之间的相互作用.
更多相关视频
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
154
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
154
What is Monogastric Digestion?
70.9K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
70.9K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K


